|
Quaternary Solid Dispersion System containing Rebamipide with Enhanced Solubility
|
| Dae Yeong Cho, Moon Jung Kim, and Kyeong Soo Kim |
| Yakhak Hoeji 2024;68(4):215-222 |
|
|
|
Analysis of Patient-Reported Outcome use status in Drug Approval Package: Focusing on novel drugs approved by FDA 2017-2023
|
| Jiyoung Ahn, Yeonjung Lim, Danbee Kang, and Juhee Cho |
| Yakhak Hoeji 2024;68(4):223-238 |
|
|
|
A Comparative Analysis of Current Status of Electronically Provided Package Leaflets (e-labels) among South Korea, the United States, Europe, Japan, and Singapore
|
| Jaesung Lee, Jinwook Yang, and Kyenghee Kwon |
| Yakhak Hoeji 2024;68(4):239-251 |
|
|
|
Development and Dissolution Behavior of Dual-Release Matrix Tablet Based on QbD
|
| Purevdorj Otgonkhishig, Suhwan Lee, Myung-Chul Gil, Young Ho Cho, and Gye Won Lee |
| Yakhak Hoeji 2024;68(4):252-268 |
|
|
|
Development of Febuxostat Solid Dispersion using a Melting Method
|
| Jun Sik Ham, Jae-Seon Kim, and Jin-Seok Choi |
| Yakhak Hoeji 2024;68(4):269-275 |
|
|
|
Applicability of KEAP1 E3 Ligase to the PROTAC Platform
|
| Raju Gurung, Jae Rim Lee, Min Ju Cho, Jin Ah Jeong, Sung Jean Park, Kwang Won Jeong, and Dongyun Shin |
| Yakhak Hoeji 2024;68(4):276-286 |
|
|
|
Analytical Method Validation of Antibody to Hepatitis B Surface Antigen Assay for Immunoglobulin Products in National Lot Release
|
| Su Kyoung Seong, Hyun Jeong Kim, Yun Su Bang, Kyung Hee Sohn, Young Hoon Kim, Kiwon Han, and Chan Woong Choi |
| Yakhak Hoeji 2024;68(4):287-293 |
|
|
|
Case Study on the Evaluation of Measurement Uncertainty in the Potency Assay for Hepatitis B Immunoglobulin
|
| Chan Woong Choi, Hyung Sil Moon, Yun Su Bang, Seong Suk Son, and Young Hoon Kim |
| Yakhak Hoeji 2024;68(4):294-301 |
|
|
Yakhak Hoeji 2024;68(4):215-301
